173 related articles for article (PubMed ID: 17638075)
1. Lyso-GM3, its dimer, and multimer: their synthesis, and their effect on epidermal growth factor-induced receptor tyrosine kinase.
Murozuka Y; Watanabe N; Hatanaka K; Hakomori SI
Glycoconj J; 2007 Dec; 24(9):551-63. PubMed ID: 17638075
[TBL] [Abstract][Full Text] [Related]
2. Effect of lipid mimetics of GM3 and lyso-GM3 dimer on EGF receptor tyrosine kinase and EGF-induced signal transduction.
Haga Y; Hatanaka K; Hakomori SI
Biochim Biophys Acta; 2008 Mar; 1780(3):393-404. PubMed ID: 18036568
[TBL] [Abstract][Full Text] [Related]
3. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor.
Hanai N; Nores GA; MacLeod C; Torres-Mendez CR; Hakomori S
J Biol Chem; 1988 Aug; 263(22):10915-21. PubMed ID: 2839511
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
6. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
[TBL] [Abstract][Full Text] [Related]
7. Effects of gangliosides GM3 and De-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth.
Song WX; Vacca MF; Welti R; Rintoul DA
J Biol Chem; 1991 Jun; 266(16):10174-81. PubMed ID: 1645342
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor.
Yoon SJ; Nakayama K; Hikita T; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):18987-91. PubMed ID: 17142315
[TBL] [Abstract][Full Text] [Related]
9. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.
Wang XQ; Yan Q; Sun P; Liu JW; Go L; McDaniel SM; Paller AS
Cancer Res; 2007 Oct; 67(20):9986-95. PubMed ID: 17942932
[TBL] [Abstract][Full Text] [Related]
10. Effect of synthetic sialyl 2-->1 sphingosine and other glycosylsphingosines on the structure and function of the "glycosphingolipid signaling domain (GSD)" in mouse melanoma B16 cells.
Zhang Y; Iwabuchi K; Nunomura S; Hakomori S
Biochemistry; 2000 Mar; 39(10):2459-68. PubMed ID: 10704195
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of EGFR affinity to immobilized glycolipids by surface plasmon resonance.
Haga Y; Hakomori SI; Hatanaka K
Carbohydr Res; 2008 Dec; 343(18):3034-8. PubMed ID: 18828994
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor.
Wang XQ; Sun P; Paller AS
J Biol Chem; 2002 Dec; 277(49):47028-34. PubMed ID: 12354760
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of membranes simulating "glycosignaling domain" and their susceptibility to lyso-GM3.
Iwabuchi K; Zhang Y; Handa K; Withers DA; Sinaÿ P; Hakomori S
J Biol Chem; 2000 May; 275(20):15174-81. PubMed ID: 10809752
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.
Bremer EG; Schlessinger J; Hakomori S
J Biol Chem; 1986 Feb; 261(5):2434-40. PubMed ID: 2418024
[TBL] [Abstract][Full Text] [Related]
15. A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth.
Hanai N; Dohi T; Nores GA; Hakomori S
J Biol Chem; 1988 May; 263(13):6296-301. PubMed ID: 2834372
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1925-30. PubMed ID: 18272501
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides.
Miljan EA; Meuillet EJ; Mania-Farnell B; George D; Yamamoto H; Simon HG; Bremer EG
J Biol Chem; 2002 Mar; 277(12):10108-13. PubMed ID: 11796728
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s).
Suarez Pestana E; Greiser U; Sánchez B; Fernández LE; Lage A; Perez R; Böhmer FD
Br J Cancer; 1997; 75(2):213-20. PubMed ID: 9010029
[TBL] [Abstract][Full Text] [Related]
19. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.
Meuillet EJ; Mania-Farnell B; George D; Inokuchi JI; Bremer EG
Exp Cell Res; 2000 Apr; 256(1):74-82. PubMed ID: 10739654
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone.
Alves F; Borchers U; Keim H; Fortte R; Olschimke J; Vogel WF; Halfter H; Tietze LF
Glycobiology; 2002 Aug; 12(8):517-22. PubMed ID: 12145192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
